Purity Information Exchange (PIE) – AI-Driven Clinical Trial Acceleration

The Purity Information Exchange (PIE) is a next-generation, AI-powered platform purpose-built to transform the speed, efficiency, and accuracy of clinical research. Developed specifically for Sponsors, CROs, and trial sites, PIE integrates patient recruitment, data aggregation, and real-time monitoring into a single, secure, and compliant ecosystem.

Purity Information Exchange - Key Capabilities

    • PIE utilizes advanced AI algorithms to identify eligible patients across our national network of clinical trial sites.

    • Matches study-specific inclusion/exclusion criteria—even for complex, multi-factor protocols—within seconds.

    • Significantly reduces recruitment time compared to industry norms.

    • Integrates with many Electronic Medical Records including most of the top ambulatory systems.

    • Aggregates data across Electronic Medical Records (EMR), Clinical Trial Management Systems (CTMS), Electronic Patient Reported Outcomes (ePRO) and Electronic Data Capture (EDC) platforms for unified reporting and analytics.

    • Automates recruitment workflows, pre-screening, and eligibility verification.

    • Reduces administrative burden and manual data handling, delivering significant savings for Sponsors.

    • Fully compliant with HIPAA, GDPR, and FDA 21 CFR Part 11 standards.

    • Features integrated audit trails, secure user authentication, and role-based access controls.

    • Employs enterprise-grade encryption for all data in transit and at rest.

    • Continuous system monitoring with intrusion detection and prevention protocols.

    • Predicts enrollment timelines and identifies at-risk sites for early intervention.

    • Adapts recruitment strategies in real time to ensure study milestones are met or exceeded.em description

  • Built to manage single-site trials or global, multi-country studies with equal efficiency.

The Purity Health Strategic Advantage

Compared to the manual recruitment and data aggregation processes used by most CROs, PIE delivers measurable acceleration in trial start-up and patient enrollment. By uniting AI-driven patient identification with deep system interoperability, PIE helps Sponsors bring promising therapeutics to market faster—reducing both time-to-market risk and capital burn.